To be screened or not to be screened? Modeling the consequences of PSA screening for the individual

BACKGROUND: Screening with prostate-specific antigen (PSA) can reduce prostate cancer mortality, but may advance diagnosis and treatment in time and lead to overdetection and overtreatment. We estimated benefits and adverse effects of PSA screening for individuals who are deciding whether or not to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Wever, E M, Hugosson, J, Heijnsdijk, E A M, Bangma, C H, Draisma, G, de Koning, H J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2012
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3425982/
https://ncbi.nlm.nih.gov/pubmed/22805324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.317
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak